Stage II Breast Cancer Completed Phase 2 Trials for Lapatinib (DB01259)

IndicationStatusPhase
DBCOND0029484 (Stage II Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01688609Lapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast CancerTreatment